Akums Drugs and Pharmaceutical (AKUMS.BO)
- Previous Close
518.75 - Open
518.90 - Bid 560.05 x --
- Ask 560.60 x --
- Day's Range
517.10 - 563.00 - 52 Week Range
407.40 - 1,174.85 - Volume
29,901 - Avg. Volume
32,443 - Market Cap (intraday)
85.829B - Beta (5Y Monthly) --
- PE Ratio (TTM)
55.73 - EPS (TTM)
10.06 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
750.00
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and is based in Delhi, India.
www.akums.in7,388
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: AKUMS.BO
View MorePerformance Overview: AKUMS.BO
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AKUMS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AKUMS.BO
View MoreValuation Measures
Market Cap
79.42B
Enterprise Value
76.48B
Trailing P/E
51.55
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.06
Price/Book (mrq)
2.80
Enterprise Value/Revenue
1.99
Enterprise Value/EBITDA
17.92
Financial Highlights
Profitability and Income Statement
Profit Margin
3.72%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
40.1B
Net Income Avi to Common (ttm)
1.49B
Diluted EPS (ttm)
10.06
Balance Sheet and Cash Flow
Total Cash (mrq)
7.95B
Total Debt/Equity (mrq)
18.63%
Levered Free Cash Flow (ttm)
--